| Walmart Pharmacy 10-2038 | |
| 45415 Dulles Crossing Plz, Sterling, Virginia 20166 | |
| (571) 434-9409 |
| Name | Walmart Pharmacy 10-2038 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 45415 Dulles Crossing Plz, Sterling, Virginia 20166 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (571) 434-9409 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
A new five-year, $6.25 million grant from the National Institutes of Health will help investigators from Northwestern University, the University of Chicago and others across the city of Chicago work together to slow and stop HIV.
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
› Verified 2 days ago
| NPI Number | 1992722094 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY 10-2038 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 45415 Dulles Crossing Plz, Sterling, VA 20166 |
| Phone Number | 571-434-9409 |
News Archive
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
A new five-year, $6.25 million grant from the National Institutes of Health will help investigators from Northwestern University, the University of Chicago and others across the city of Chicago work together to slow and stop HIV.
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
› Verified 2 days ago
News Archive
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.
A new five-year, $6.25 million grant from the National Institutes of Health will help investigators from Northwestern University, the University of Chicago and others across the city of Chicago work together to slow and stop HIV.
Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.
› Verified 2 days ago
Cranial Technologies, Inc. Type: Prosthetic/Orthotic Supplier Location: 14 Pidgeon Hill Dr, Sterling, Virginia 20165 Phone: (703) 433-1450 | |
Visionworks Doctors Of Optometry Type: Eyewear Supplier (Equipment, not the service) Location: 21031 Triple Seven Rd, Sterling, Virginia 20165 Phone: (703) 444-1462 | |
Giant Pharmacy #762 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21800 Town Center Plaza, Sterling, Virginia 20164 Phone: (703) 430-1818 | |
Giant Pharmacy #794 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21000 Southbank St 150, Sterling, Virginia 20165 Phone: (703) 430-0400 | |
Harris Teeter Pharmacy #326 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21399 Epicerie Plz, Sterling, Virginia 20164 Phone: (571) 665-5025 |